High‐Throughput Separation of Microvesicles from Whole Blood Components Using Viscoelastic Fluid
Source abstract
Abstract
Abstract Cell‐derived microvesicles (MVs, also known as microparticles, MPs) are known as important biomarkers of various diseases including cardiovascular diseases, infectious diseases, and cancer. Development of techniques for blood cell removal and MV isolation is required for downstream analyses in biological and clinical applications. A sheathless, label‐free, viscoelastic microfluidic device is proposed for the separation of submicrometer platelet‐derived MPs (PDMPs) from whole blood. Flow rate and channel length dependent performance of the device is evaluated using 2‐µm particles as analogs to platelets and hematocrit (Hct) dependent flow characteristics of red blood cells (RBCs) are observed. In addition, the removal rate of nanoparticles of sizes 300, 500, 700, and 1000 nm is evaluated, and finally, the device is applied to examine the recovery of PDMPs from diluted whole blood sample. At Q = 200 µL min−1 in a 15‐mm long microchannel, RBCs at 5% Hct and platelets are removed to the central outlet without platelet activation, while PDMPs are successfully isolated to the side outlets within ≈2 min. The PDMPs collected from the device are analyzed by flow cytometry. The device exhibits ≈4.8‐fold enhanced isolation performance compared to the centrifugation method.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Blood properties and coagulation · Lattice Boltzmann Simulation Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Laboratory Medicine College of Medicine Korea University 226 Gamasan‐ro, Guro‐gu Seoul 08308 Korea
Department of Emergency Medicine College of Medicine Korea University 226 Gamasan‐ro, Guro‐gu Seoul 08308 Korea
Department of Medical Sciences Graduate School of Medicine Korea University Seoul 02841 Korea
Funding
National Research Foundation of Korea · National Science Foundation, United Arab Emirates · Korea Health Industry Development Institute · Ministry of Health and Welfare
References (91)
Show source-provided references
1. 10.1182/blood-2012-10-46179810.1182/blood-2012-10-461798 ↗
2. 10.1038/sj.cdd.440223710.1038/sj.cdd.4402237 ↗
3. 10.1038/7749810.1038/77498 ↗
4. 10.2147/DMSO.S3292310.2147/DMSO.S32923 ↗
5. 10.1038/ncb159610.1038/ncb1596 ↗
6. 10.1111/j.1538-7836.2005.01646.x10.1111/j.1538-7836.2005.01646.x ↗
7. 10.1161/ATVBAHA.110.21812310.1161/ATVBAHA.110.218123 ↗
8. 10.1161/CIRCRESAHA.112.30081810.1161/CIRCRESAHA.112.300818 ↗
9. 10.18433/J3989X10.18433/J3989X ↗
10. 10.1016/j.blre.2014.04.00210.1016/j.blre.2014.04.002 ↗
11. 10.1016/j.tcb.2008.11.00310.1016/j.tcb.2008.11.003 ↗
12. 10.1016/j.medmal.2012.05.01110.1016/j.medmal.2012.05.011 ↗
13. 10.1016/j.blre.2006.09.00110.1016/j.blre.2006.09.001 ↗
14. 10.1039/C5LC00290G10.1039/C5LC00290G ↗
15. 10.1111/j.1538-7836.2004.00936.x10.1111/j.1538-7836.2004.00936.x ↗
16. 10.1016/j.ymeth.2012.01.00210.1016/j.ymeth.2012.01.002 ↗
17. 10.1111/j.1538-7836.2011.04610.x10.1111/j.1538-7836.2011.04610.x ↗
18. 10.1038/am.2017.17510.1038/am.2017.175 ↗
19. 10.1039/c2lc41006k10.1039/c2lc41006k ↗
20. 10.1039/C9AN01235D10.1039/C9AN01235D ↗
21. 10.1038/s41598-017-08826-w10.1038/s41598-017-08826-w ↗
22. 10.1007/s10544-014-9891-z10.1007/s10544-014-9891-z ↗
23. 10.1021/nn506538f10.1021/nn506538f ↗
24. 10.1073/pnas.170921011410.1073/pnas.1709210114 ↗
25. 10.1016/j.jnnfm.2010.01.02410.1016/j.jnnfm.2010.01.024 ↗
26. 10.1146/annurev-fluid-010816-06015010.1146/annurev-fluid-010816-060150 ↗
27. 10.1016/j.ces.2014.12.01910.1016/j.ces.2014.12.019 ↗
28. 10.1063/1.494462810.1063/1.4944628 ↗
29. 10.1103/PhysRevLett.98.23450110.1103/PhysRevLett.98.234501 ↗
30. 10.1016/j.talanta.2018.12.10210.1016/j.talanta.2018.12.102 ↗
31. 10.3390/mi1007046210.3390/mi10070462 ↗
32. 10.1038/s41598-018-37186-210.1038/s41598-018-37186-2 ↗
33. 10.1039/c2lc21304d10.1039/c2lc21304d ↗
34. 10.1016/j.chroma.2015.06.02910.1016/j.chroma.2015.06.029 ↗
35. 10.1039/C6LC00162A10.1039/C6LC00162A ↗
36. 10.1063/1.493838910.1063/1.4938389 ↗
37. 10.1039/C6LC00843G10.1039/C6LC00843G ↗
38. 10.1021/acsnano.7b0227710.1021/acsnano.7b02277 ↗
39. 10.1161/CIRCRESAHA.110.22645610.1161/CIRCRESAHA.110.226456 ↗
40. Y.Miyazaki S.Nomura T.Miyake H.Kagawa C.Kitada H.Taniguchi Y.Komiyama Y.Fujimura Y.Ikeda S.Fukuhara 1996 88 3456.10.1182/blood.V88.9.3456.bloodjournal8893456 ↗
41. 10.1080/0953710005012927910.1080/09537100050129279 ↗
42. 10.1016/S0021-9258(19)81346-710.1016/S0021-9258(19)81346-7 ↗
43. 10.1080/0036551070179495710.1080/00365510701794957 ↗
44. 10.1016/j.healun.2007.09.03110.1016/j.healun.2007.09.031 ↗
45. 10.1373/clinchem.2005.05741410.1373/clinchem.2005.057414 ↗
46. 10.2147/IJGM.S23616610.2147/IJGM.S236166 ↗
47. 10.1002/art.1031210.1002/art.10312 ↗
48. 10.1016/j.ijgo.2008.04.00710.1016/j.ijgo.2008.04.007 ↗
49. Wang M. · Exp. Ther. Med. · 2018 · 16 · 3099
50. 10.1111/jth.1220710.1111/jth.12207 ↗
51. 10.1039/C3RA43522A10.1039/C3RA43522A ↗
52. 10.1122/1.55077310.1122/1.550773 ↗
53. 10.1038/s41598-019-39175-510.1038/s41598-019-39175-5 ↗
54. 10.1039/b513524a10.1039/b513524a ↗
55. 10.1039/C3RA46708B10.1039/C3RA46708B ↗
56. 10.1038/srep2603210.1038/srep26032 ↗
57. 10.1016/j.mee.2014.10.01310.1016/j.mee.2014.10.013 ↗
58. 10.1111/aor.1243810.1111/aor.12438 ↗
59. 10.3402/jev.v3.2469210.3402/jev.v3.24692 ↗
60. 10.1021/jacs.9b0000710.1021/jacs.9b00007 ↗
61. 10.1016/j.snb.2015.03.03810.1016/j.snb.2015.03.038 ↗
62. 10.1038/srep0487110.1038/srep04871 ↗
63. 10.2302/kjm.53.21010.2302/kjm.53.210 ↗
64. 10.1111/j.1538-7836.2008.03200.x10.1111/j.1538-7836.2008.03200.x ↗
65. 10.2147/VHRM.S95510.2147/VHRM.S955 ↗
66. C. S.Abrams N.Ellison A.Budzynski S.Shattil 1990 75 128.10.1182/blood.V75.1.128.bloodjournal751128 ↗
67. 10.1111/jth.1374510.1111/jth.13745 ↗
68. 10.1183/09031936.0010740810.1183/09031936.00107408 ↗
69. 10.1016/j.thromres.2010.12.01410.1016/j.thromres.2010.12.014 ↗
70. 10.1016/j.bios.2014.10.05610.1016/j.bios.2014.10.056 ↗
71. 10.1016/j.bios.2016.08.10010.1016/j.bios.2016.08.100 ↗
72. Lake M. · Protoc. Exch. · 2015 · 10
73. 10.1039/C3LC50887K10.1039/C3LC50887K ↗
74. 10.1016/j.snb.2018.04.07510.1016/j.snb.2018.04.075 ↗
75. 10.1039/C9RA08368E10.1039/C9RA08368E ↗
76. 10.1186/1471-2121-14-2310.1186/1471-2121-14-23 ↗
77. 10.1371/journal.pone.010420010.1371/journal.pone.0104200 ↗
78. 10.1182/blood.V95.3.930.003k46_930_93510.1182/blood.V95.3.930.003k46_930_935 ↗
79. 10.1016/j.thromres.2017.03.02510.1016/j.thromres.2017.03.025 ↗
80. 10.3390/ijms2020522710.3390/ijms20205227 ↗
81. 10.1016/j.bbadis.2017.01.01210.1016/j.bbadis.2017.01.012 ↗
82. 10.1016/j.ijcard.2016.11.30210.1016/j.ijcard.2016.11.302 ↗
83. 10.2147/COPD.S17560710.2147/COPD.S175607 ↗
84. Dey‐Hazra E. · Vasc. Health Risk Manage. · 2010 · 6 · 1125
85. 10.1038/s41467-019-10360-410.1038/s41467-019-10360-4 ↗
86. 10.1186/s12929-016-0224-910.1186/s12929-016-0224-9 ↗
87. 10.3324/haematol.2012.06616710.3324/haematol.2012.066167 ↗
88. 10.1186/s12885-017-3102-210.1186/s12885-017-3102-2 ↗
89. 10.1126/sciadv.aay978910.1126/sciadv.aay9789 ↗
90. 10.1111/j.1538-7836.2010.04047.x10.1111/j.1538-7836.2010.04047.x ↗
91. 10.1111/jth.1351410.1111/jth.13514 ↗